WallStreetZenWallStreetZen

NASDAQ: JAGX
Jaguar Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their JAGX stock forecasts and price targets.

Forecast return on equity

Is JAGX forecast to generate an efficient return?

Company
-384.64%
Industry
8.86%
Market
330.44%
JAGX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is JAGX forecast to generate an efficient return on assets?

Company
-43.75%
Industry
10.21%
JAGX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

JAGX earnings per share forecast

What is JAGX's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$24.29
Avg 2 year Forecast
-$5.79

JAGX revenue forecast

What is JAGX's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$14.3M+21.41%
Avg 2 year Forecast
$18.6M+57.83%
JAGX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

JAGX revenue growth forecast

How is JAGX forecast to perform vs Biotechnology companies and vs the US market?

Company
21.41%
Industry
9,891.48%
Market
1,454.48%
JAGX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
JAGX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

JAGX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
JAGX$1.10N/AN/A
SXTP$0.98$4.40+348.98%Buy
AZTR$0.38N/AN/A
OGEN$0.94N/AN/A
CANF$0.33$6.75+1,964.22%Strong Buy
View Top Biotech Stocks

Jaguar Health Stock Forecast FAQ

What is JAGX's earnings growth forecast for 2025-2026?

(NASDAQ: JAGX) Jaguar Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 205.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,935.09%.

Jaguar Health's earnings in 2025 is -$40,293,000.On average, 3 Wall Street analysts forecast JAGX's earnings for 2025 to be -$90,729,285, with the lowest JAGX earnings forecast at -$87,171,273, and the highest JAGX earnings forecast at -$93,397,793.

In 2026, JAGX is forecast to generate -$21,643,945 in earnings, with the lowest earnings forecast at -$20,795,163 and the highest earnings forecast at -$22,280,532.

If you're new to stock investing, here's how to buy Jaguar Health stock.

What is JAGX's revenue growth forecast for 2025-2026?

(NASDAQ: JAGX) Jaguar Health's forecast annual revenue growth rate of 21.41% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 9,891.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,454.48%.

Jaguar Health's revenue in 2025 is $11,785,000.On average, 3 Wall Street analysts forecast JAGX's revenue for 2025 to be $53,452,356, with the lowest JAGX revenue forecast at $51,352,815, and the highest JAGX revenue forecast at $55,021,407.

In 2026, JAGX is forecast to generate $69,486,568 in revenue, with the lowest revenue forecast at $66,759,407 and the highest revenue forecast at $71,530,071.

What is JAGX's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: JAGX) forecast ROA is -43.75%, which is lower than the forecast US Biotechnology industry average of 10.21%.

What is JAGX's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: JAGX) Jaguar Health's current Earnings Per Share (EPS) is -$41.93. On average, analysts forecast that JAGX's EPS will be -$24.29 for 2025, with the lowest EPS forecast at -$23.33, and the highest EPS forecast at -$25.00. In 2026, JAGX's EPS is forecast to hit -$5.79 (min: -$5.57, max: -$5.96).

What is JAGX's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: JAGX) forecast ROE is -384.64%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.